The Highest Standard in Peptide Research.

Bodytide Wellness Lab
RECOVERY & REPAIR

BPC-157 15MG

Rapid joint, tendon, and tissue repair

BPC-157 is a stable gastric pentadecapeptide engineered to support the rapid healing and remodeling of muscles, joints, tendons, and ligaments.

BPC-157 15MG
£149.00

Active Ingredient: 15.00mg per pen

Volume: 3.00ml

For in vitro use only.

Typical research suggests 5 clicks daily, weeks 1-2. Then 10 clicks daily thereafter.

All our Peptide Pens are designed to last a minimum of 30 days.

Taxes included. Shipping calculated at checkout.

Expected Benefits

By combining clinical research with day-to-day wellness support, this protocol offers clear metabolic improvements:

Rapid Joint Repair: Speeds up the cellular healing of damaged cartilage, ligaments, and tendons.
Tissue Remodelling: Promotes cell migration to weave dense, high-tensile collagen fibers.
Inflammation Control: Mitigates persistent joint and tissue stress, clearing stiffness.
Angiogenic Stimulation: Spurs new micro-capillary growth to deliver vital nutrients to recovery zones.
Systemic Recovery: Supports mucosal lining health throughout the digestive tract.

Manufactured and tested to
pharmaceutical standards

EU GMP ISO 9001 ISO 13485 ISO 14644
To maintain the integrity of your protocol, correct storage is essential. Always store your Peptide pen in its protective casing within the refrigerator, strictly between 2°C and 8°C. Ensure the pen is shielded from direct light and never allowed to freeze. When travelling, we recommend utilizing a temperature-controlled travel case.

What is BPC-157 15MG?

BPC-157 is a stable, synthetic peptide formula derived from a natural protective protein found in gastric juice. It communicates directly with damaged tissues to trigger rapid blood vessel growth and cell migration, accelerating the healing of muscles, joints, tendons, and ligaments.

The Cellular Mechanism

VEGFR2 Pathway: Triggers rapid blood vessel formation to rush oxygen to joint spaces.
EGR-1 Upregulation: Activates growth and matrix synthesis genes in repairing fibroblasts.

Protocol Schedule

Clinical evaluation studies show that a typical research protocol ranges from 250mcg to 500mcg daily, administered in the morning. To allow cellular receptors to adapt comfortably, researchers follow a step-by-step escalation schedule:

Weeks 1-2 (Baseline Priming): An initial daily dose of 250mcg in the morning (5 clicks once per day).

Weeks 2 Onwards (Active Titration): The protocol scales to 500mcg daily in the morning (10 clicks once per day).

Once targets are achieved, dosage can be reviewed and adjusted according to results.

Possible Side Effects

Site Redness: Minor, transient pinkness or mild tingling at the application site resolving in minutes.
Mild Digestive Shift: Temporary, minor gastrointestinal adjustments as mucosal pathways optimize.